Print this page



College of Medicine

Interim Director:

Cynthia Damer, Ph.D., University of Virginia. Cell signaling, cytoskeleton, and membrane trafficking. Office: Biosciences 3106; 989-774-3455


Program Faculty:

Richard Backs, Ph.D., University of Southern California. Human factors, psychophysiology, aging, attention, and emotion.

Peter Dijkstra, Ph.D., University of Groningen, The Netherlands. Oxidative stress, reproduction and social dominance, social network analysis. 

Gary Dunbar, Ph.D., Clark University. Stem cell, dietary supplements, and pharmacological therapies for neurodegenerative diseases, including Huntington’s, Alzheimer’s, and Parkinson’s diseases.

Ute Hochgeschwender, M.D., Free University Berlin, Germany. Development and applications of bioluminescent optogenetic tools.

Kenneth Jenrow, Ph.D., Oakland University. Electrophysiology, investigating the deleterious effects of neuroinflammation on waste clearance, synaptic plasticity, and cognitive function.

Lixin Li, M.D., Southeast University Medical School, China. Ph.D., Norwegian University of Science & Technology. Liraglutide and its protective role in neurodegenerative disease, obesity, type 2 diabetes, metabolic syndrome.

Yannick Marchalant, Ph.D., Université de Caen, France. Influence of brain aging and neuroinflammatory processes on the development of neurodegenerative diseases.

Kevin Park, Ph.D., University of Illinois at Urbana-Champaign. Pathological mechanisms of sporadic Alzheimer's Disease, neuroinflammation, amyloid pathology, tau pathology, senescence.

Robert B. Petersen, Ph.D., University of Minnesota. Neurodegeneration, cell and animal models, genetics, prions, protein misfolding disorders, aging.

Mark Reilly, Ph.D., West Virginia University. Experimental analysis of behavior, operant/respondent conditioning, animal learning, quantitative models, behavioral pharmacology, and substance abuse.

Julien Rossignol, Ph.D., Nantes University, France. Molecular biology, neuroimmunology, nanoparticle gene therapy, Huntington's disease, glioblastoma, stroke, stem cell therapy in the context of neurodegenerative diseases.

Shasta Sabo, Ph.D., Rockefeller University. Cellular and molecular mechanisms of neuronal development, synapse formation, Autism and other neurodevelopmental disorders, NMDA receptors, cellular imaging, live imaging, neuropharmacology.

Michael Sandstrom, Ph.D., Ohio State University. Assessing brain plasticity, compensatory neuronal activity, or neurochemical control during active behavior at various stages of deteriorative brain diseases, such as Parkinson’s and Huntington’s using animal models.

Naveen Sharma, Ph.D., Case Western Reserve University.  Mechanisms of aging, dietary and exercise interventions.

Reid Skeel, Ph.D., University of Florida. Functional applications of neuropsychological assessments.

Michelle Steinhilb, Ph.D., University of Michigan. Genetic models of human neurodegenerative disease, cellular and molecular neurobiology.

Ksenia Ustinova, Ph.D., Russian State University of Sport. Motor control and learning, rehabilitation of patients with neurological diseases including stroke, spinocerebellar ataxia, Parkinson’s disease.


Course Designator:

NSC - Neuroscience

The Programs:

Master of Science (M.S.) in Neuroscience

Doctor of Philosophy (Ph.D.) in Neuroscience